v3.26.1
Equity Plans (Tables)
9 Months Ended
May 29, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Aggregate Restricted Award Activity and Assumptions
Restricted Award activity was as follows:
Three Months EndedNine Months Ended
May 29,
2026
May 30,
2025
May 29,
2026
May 30,
2025
Restricted awards granted1391,3232,4782,006
Weighted-average grant date fair value per share$21.47 $17.09 $20.88 $18.35 
Aggregate vesting date fair value of shares vested$9,443 $6,091 $31,062 $25,768 
Schedule of Share Based Compensation Expense Allocation
Stock-based compensation expense for our continuing operations was as follows:
Three Months EndedNine Months Ended
May 29,
2026
May 30,
2025
May 29,
2026
May 30,
2025
Stock-based compensation expense by caption:
Cost of sales$1,411 $1,393 $4,319 $4,812 
Research and development1,612 1,531 4,742 4,818 
Selling, general and administrative6,973 7,327 16,134 23,732 
 $9,996 $10,251 $25,195 $33,362